Haemonetics HAE Business Segments
| TTM Q4 '26 | TTM Q3 '26 | TTM Q2 '26 | TTM Q1 '26 | TTM Q4 '25 | ||
|---|---|---|---|---|---|---|
| Net revenues by Business | ||||||
| Blood Center | $221.27M-15.3% | $220.86M— | $234.64M— | $246.72M— | $261.12M— | |
| Hospital | $588.3M+4.3% | $576.51M— | $576.99M— | $569.91M— | $564.27M— | |
| Plasma | $524.46M-2.0% | $520.9M— | $516.22M— | $529.42M— | $535.43M— | |
| Total net revenues by Product | ||||||
| Plasma | $524.46M-2.0% | $520.9M-5.0% | $516.22M-8.1% | $529.42M-6.4% | $535.43M-6.0% | |
| Net revenues by Geography | ||||||
| Europe | $185.02M+5.3% | $174.4M+0.6% | $170.29M+0.6% | $169.31M+1.2% | $175.66M+9.7% | |
| Japan | $68.2M+9.3% | $65.9M+8.3% | $63.94M+8.1% | $62.35M+8.9% | $62.41M+7.4% | |
| Other | $11.42M-41.5% | $11.08M-44.9% | $14.21M-23.1% | $15.79M-4.4% | $19.54M+47.1% | |
| Rest of Asia | $87.21M-5.5% | $88.4M-9.8% | $90.97M-8.4% | $94.17M-6.2% | $92.31M-14.2% | |
| United States | $982.18M-2.8% | $978.5M-2.6% | $988.45M-0.2% | $1B+2.9% | $1.01B+4.2% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Haemonetics break its business down?
- Haemonetics (HAE) reports net revenues by business across 3 parts — Blood Center, Hospital and Plasma. Each is extracted from the segment footnotes and tracked over time.
- Where does Haemonetics's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Haemonetics's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.